Oregon Cannabis Regulation: Licensing, Laws, and Compliance Guide

Executive Summary

Oregon operates one of the most mature adult-use cannabis markets in the United States, but faces persistent regulatory and fiscal challenges stemming from oversupply, price collapse, and underfunded oversight. The state legalized recreational cannabis through Measure 91 in 2014, launching retail sales in October 2016 under the Oregon Liquor and Cannabis Commission (OLCC). By mid-2026, Oregon's cannabis regulatory apparatus confronts a financial crisis severe enough to trigger a merger between cannabis and psilocybin oversight divisions, reflecting broader structural tensions in a market characterized by thousands of licensed operators, wholesale flower prices below $300 per pound, and tax revenues falling short of enforcement needs. The state's experience offers critical lessons for jurisdictions balancing access, public health, market sustainability, and regulatory capacity. Oregon's regulatory framework encompasses seed-to-sale tracking through the Cannabis Tracking System (CTS), strict testing requirements, local control provisions allowing municipal bans, and a tiered licensing structure that has produced one of the nation's highest per-capita concentrations of cannabis retailers. Understanding Oregon's regulatory evolution is essential for operators, investors, policymakers, and patients navigating the complexities of state-legal cannabis markets operating without federal recognition.

Why Oregon's Cannabis Regulation Matters

Oregon's regulatory model directly affects more than 3,800 active cannabis licenses, approximately $1.2 billion in annual retail sales, tens of thousands of jobs, and serves as a cautionary tale for states designing their own frameworks. The state's approach to cannabis regulation carries implications across multiple stakeholder groups. For licensed operators, Oregon's regulatory structure determines operating costs, compliance burdens, market entry barriers, and competitive dynamics in an oversaturated market where profit margins have compressed dramatically since 2018. The OLCC oversees producers, processors, wholesalers, retailers, laboratories, and research certificate holders, each subject to distinct licensing fees, operational requirements, and inspection protocols. For consumers and patients, Oregon maintains both a recreational market and a separate Oregon Medical Marijuana Program (OMMP) administered by the Oregon Health Authority, creating parallel regulatory tracks with different possession limits, tax treatment, and product access rules. Medical cardholders can possess up to 24 ounces of usable cannabis and grow up to six mature plants, while recreational users face an eight-ounce home possession limit and four-plant cultivation cap. The fiscal dimension proves particularly significant. Oregon's 17 percent retail cannabis tax generated approximately $190 million in state revenue during fiscal year 2025, distributed across the State School Fund (40 percent), mental health and addiction services (20 percent), state police (15 percent), cities and counties (10 percent each), and the Oregon Health Authority (5 percent). However, these revenues have plateaued while regulatory costs continue rising, creating the budget shortfall that precipitated the 2026 merger announcement. Oregon's experience also matters for federal policy debates. As Congress considers rescheduling cannabis from Schedule I to Schedule III under the Controlled Substances Act (21 U.S.C. § 812), Oregon's decade of implementation data provides empirical evidence on market maturation, tax policy effectiveness, public health outcomes, and regulatory sustainability that informs national discussions.

Background and History: Oregon's Path to Legal Cannabis

Oregon's cannabis policy evolved through five decades of incremental reform, from pioneering decriminalization in 1973 to establishing one of the nation's first adult-use markets in 2016.

Early Decriminalization (1973)

Oregon became the first state to decriminalize cannabis possession when it passed legislation in 1973 reducing possession of less than one ounce from a felony to a violation punishable by a maximum $100 fine. This pioneering reform, predating California's Proposition 215 by more than two decades, established Oregon as a progressive outlier on cannabis policy and created a foundation for subsequent liberalization.

Medical Cannabis Authorization (1998)

On November 3, 1998, Oregon voters approved Ballot Measure 67 with 55 percent support, establishing the Oregon Medical Marijuana Act (OMMA). The law authorized patients with debilitating medical conditions—including cancer, glaucoma, HIV/AIDS, and conditions causing cachexia, severe pain, seizures, or persistent muscle spasms—to possess and cultivate cannabis with a physician's recommendation. The Oregon Health Authority began registering patients in May 1999, initially allowing possession of up to three mature plants, four immature plants, and one ounce of usable cannabis per patient. The program expanded significantly over subsequent years. A 2005 amendment increased possession limits to six mature plants, 18 immature plants, and 24 ounces of usable cannabis. By 2013, Oregon had registered more than 56,000 medical cannabis patients, one of the highest per-capita rates nationally, though the program operated without state-licensed dispensaries—patients relied on designated caregivers or home cultivation.

Dispensary System Establishment (2013)

Senate Bill 1544, enacted in 2013, created Oregon's first regulated medical cannabis dispensary system. The Oregon Health Authority began licensing dispensaries in March 2014, authorizing retail sales to registered patients. By October 2015, approximately 250 medical dispensaries operated statewide, providing the infrastructure that would later facilitate recreational market launch.

Measure 91 and Adult-Use Legalization (2014)

On November 4, 2014, Oregon voters approved Ballot Measure 91 with 56 percent support, legalizing recreational cannabis for adults 21 and older. The measure allowed possession of up to eight ounces in a residence and one ounce in public, permitted home cultivation of up to four plants per household, and directed the Oregon Liquor Control Commission (later renamed the Oregon Liquor and Cannabis Commission) to develop a comprehensive regulatory and licensing framework. Measure 91 established a 17 percent retail sales tax on recreational cannabis, prohibited consumption in public places, and preserved employer rights to maintain drug-free workplaces. Critically, the measure included strong local control provisions allowing cities and counties to ban cannabis businesses through local ordinances or voter initiatives—a feature that would significantly shape market geography.

Early Sales and Market Launch (2015-2016)

Oregon implemented an unusual transitional approach. On October 1, 2015, personal possession and home cultivation became legal, but no licensed recreational retailers yet existed. To address this gap, the legislature passed House Bill 3400 allowing existing medical dispensaries to sell limited quantities of cannabis to any adult 21 or older beginning October 1, 2015, creating "early sales" that generated immediate tax revenue while the OLCC developed full licensing rules. The OLCC accepted the first recreational license applications in January 2016. The first licensed recreational dispensaries opened on October 1, 2016, exactly two years after possession became legal. By December 2016, more than 250 recreational retailers operated statewide, with producers and processors rapidly scaling operations to meet anticipated demand.

Market Maturation and Oversupply Crisis (2017-2020)

Oregon's cannabis market expanded explosively between 2016 and 2018. The OLCC adopted a relatively permissive licensing approach with no statewide caps on license numbers, leading to rapid proliferation. By mid-2018, Oregon had licensed more than 1,000 producers cultivating cannabis on more than 1,000 acres of canopy, creating production capacity far exceeding in-state demand. The oversupply crisis manifested in collapsing wholesale prices. Wholesale flower prices, which averaged approximately $1,500 per pound in early 2016, fell below $500 per pound by late 2018 and continued declining. By 2020, wholesale prices for outdoor-grown flower frequently traded below $300 per pound, and some distressed inventory sold for under $100 per pound. This price collapse devastated producer margins, triggered widespread business failures, and created conditions favorable to diversion into illicit interstate markets. The OLCC responded with several interventions. In 2018, the agency imposed a temporary moratorium on new producer license applications, though existing applicants in the queue continued receiving approvals. The legislature passed Senate Bill 218 in 2019, directing the OLCC to limit total statewide canopy to address oversupply, though implementation proved politically and administratively challenging.

Regulatory Refinements and Testing Standards (2018-2022)

Oregon continuously refined its regulatory framework throughout this period. In 2018, the OLCC implemented stricter testing requirements, mandating analysis for potency, pesticides, solvents, and microbial contaminants. The state adopted action levels for 59 pesticides and established pass/fail thresholds for molds, bacteria, and mycotoxins. The agency also enhanced seed-to-sale tracking requirements through the Cannabis Tracking System (CTS), built on the METRC platform. All licensees must document every plant from seed or clone through harvest, processing, testing, and retail sale, creating a comprehensive audit trail intended to prevent diversion. In 2019, Oregon banned vitamin E acetate in vaping products following the EVALI outbreak, becoming one of the first states to prohibit the additive linked to lung injuries. The state also restricted certain packaging and marketing practices, prohibited products appealing to minors, and established serving-size limits for edibles.

COVID-19 Pandemic Impact (2020-2021)

The COVID-19 pandemic significantly affected Oregon's cannabis market. Governor Kate Brown designated cannabis retailers as essential businesses in March 2020, allowing continued operations during lockdowns. Retail sales surged during 2020, with monthly revenues increasing approximately 30 percent compared to 2019 as consumers stockpiled products and shifted spending from closed hospitality venues. However, the pandemic exacerbated existing regulatory challenges. OLCC inspection capacity declined due to remote work requirements and staff illness. Compliance investigations slowed. The backlog of license applications grew. These strains contributed to the agency's mounting fiscal pressures.

Psilocybin Legalization and Regulatory Expansion (2020-2023)

On November 3, 2020, Oregon voters approved Measure 109 with 56 percent support, creating the nation's first legal psilocybin services program. The measure directed the Oregon Health Authority to develop a licensing framework for psilocybin service centers and facilitators, establishing a regulated access model for therapeutic psilocybin use. The OHA began accepting applications in January 2023 and issued the first licenses in June 2023. By mid-2026, approximately 75 psilocybin service centers operated statewide, representing a small but growing regulatory portfolio. The program operates on a fee-funded model similar to cannabis regulation, but with a much smaller revenue base, contributing to the fiscal pressures that prompted the 2026 merger announcement.

Recent Developments and Fiscal Crisis (2024-2026)

By 2024, Oregon's cannabis regulatory system faced mounting challenges. Tax revenues plateaued as retail sales growth stalled and price compression continued. The OLCC's cannabis division operated with approximately 90 full-time employees managing more than 3,800 active licenses, creating a ratio of roughly 42 licenses per regulator—among the highest in the nation. Enforcement capacity proved insufficient to address a growing illicit market. Federal authorities estimated that Oregon produces significantly more cannabis than its 4.2 million residents consume, with surplus production feeding interstate trafficking networks. In 2024, the U.S. Attorney's Office for the District of Oregon prosecuted multiple large-scale diversion operations involving nominally licensed producers. The fiscal crisis culminated in July 2026 when Oregon officials announced plans to merge cannabis and psilocybin regulatory divisions to reduce administrative overhead and share resources. According to reporting by Willamette Week, the merger aims to address budget shortfalls while maintaining regulatory effectiveness across both programs.

Key Players in Oregon Cannabis Regulation

Oregon's cannabis regulatory ecosystem involves multiple state agencies, industry associations, local governments, and advocacy organizations, each playing distinct roles in policy development and implementation.

Oregon Liquor and Cannabis Commission (OLCC)

The OLCC serves as Oregon's primary cannabis regulatory authority, responsible for licensing, compliance monitoring, enforcement, and rule-making for recreational cannabis. The agency operates under the Oregon Revised Statutes Chapter 475C and Oregon Administrative Rules Chapter 845, Division 25. The five-member commission, appointed by the governor and confirmed by the Senate, sets policy direction, while a professional staff of approximately 90 employees implements day-to-day regulation. The OLCC's cannabis division manages seven license types: producer, processor, wholesaler, retailer, laboratory, research certificate, and temporary sales. As of June 2026, the agency oversees approximately 1,850 producer licenses, 1,100 retailer licenses, 650 processor licenses, 150 wholesaler licenses, and 50 laboratory licenses. The agency collects licensing fees ranging from $250 for temporary sales licenses to $5,750 for producer licenses, generating approximately $12 million annually in fee revenue—insufficient to cover the division's $18 million operating budget.

Oregon Health Authority (OHA)

The OHA administers the Oregon Medical Marijuana Program (OMMP), maintaining a separate regulatory track for medical cannabis patients and designated caregivers. As of mid-2026, approximately 38,000 patients hold active OMMP registrations, down from a peak of 76,000 in 2016 before recreational sales began. The OHA charges a $200 annual registration fee ($60 for patients receiving SNAP benefits), generating approximately $6 million in annual revenue. The OHA also oversees the psilocybin services program established by Measure 109, licensing service centers, facilitators, manufacturers, and testing laboratories. This program operates with approximately 15 full-time employees and a budget of roughly $3 million annually, funded entirely through licensing fees and service charges.

Oregon Department of Revenue

The Department of Revenue collects the 17 percent state cannabis tax and distributes revenues according to the statutory formula established in Measure 91. The department also administers local cannabis taxes adopted by approximately 80 cities and counties, which range from 3 percent to 10 percent of retail sales. Tax compliance and audit functions fall under the department's jurisdiction, including investigations of unreported sales and tax evasion.

Oregon Cannabis Association

The Oregon Cannabis Association represents licensed businesses across all license types, advocating for regulatory reforms, tax policy changes, and market stabilization measures. The association has pushed for canopy caps, license limits, and enhanced enforcement against unlicensed operators. The organization played a key role in supporting Senate Bill 218 and subsequent legislative efforts to address oversupply.

Local Governments

Cities and counties exercise significant authority over cannabis businesses through local licensing, zoning, and taxation. As of 2026, approximately 120 of Oregon's 241 cities and 15 of 36 counties have banned cannabis retailers through local ordinances or ballot measures, creating a patchwork of access that concentrates retail activity in permissive jurisdictions. Portland, Eugene, Salem, and Bend host the highest concentrations of retailers, while large rural areas remain without legal access points.

Legal and Regulatory Framework

Oregon's cannabis regulatory structure rests on state statutes, administrative rules, and local ordinances that create a comprehensive licensing, testing, and compliance system while preserving state-federal legal tensions.

Statutory Foundation

Oregon Revised Statutes Chapter 475C codifies the state's recreational cannabis program, implementing Measure 91 and subsequent legislative amendments. Key provisions include: - **Personal possession limits**: Eight ounces in a residence, one ounce in public (ORS 475C.323) - **Home cultivation**: Four plants per household, regardless of number of residents (ORS 475C.327) - **Licensing authority**: Grants OLCC comprehensive regulatory power over commercial cannabis activities (ORS 475C.065) - **Taxation**: Establishes 17 percent state retail tax and authorizes local taxes up to 3 percent (ORS 475C.784) - **Local control**: Preserves municipal authority to ban cannabis businesses (ORS 475C.153) Oregon Revised Statutes Chapter 475B governs the medical marijuana program, establishing patient registration, possession limits, and cultivation rights distinct from the recreational framework.

Administrative Rules

The OLCC implements statutory directives through Oregon Administrative Rules Chapter 845, Division 25, which spans more than 200 pages of detailed regulations covering: - **Application requirements**: Criminal background checks, financial disclosures, residency requirements, and operating plans - **Operational standards**: Security systems, inventory tracking, record-keeping, employee training, and transportation protocols - **Product standards**: Testing requirements, labeling specifications, packaging rules, and serving-size limits - **Compliance monitoring**: Inspection procedures, violation categories, and penalty schedules The rules require all licensees to use the Cannabis Tracking System (CTS) for seed-to-sale tracking, documenting every plant, harvest batch, processed product, and retail transaction. Testing laboratories must achieve and maintain ISO/IEC 17025 accreditation and participate in proficiency testing programs.

Testing and Quality Control

Oregon mandates comprehensive testing of all cannabis products before retail sale. Flower, concentrates, and edibles must undergo analysis for: - **Potency**: THC, THCA, CBD, CBDA, and other cannabinoids - **Pesticides**: 59 compounds with specific action levels - **Solvents**: Residual solvents for extracted products - **Microbial contaminants**: Aspergillus, E. coli, Salmonella, and total yeast/mold counts - **Mycotoxins**: Aflatoxins and ochratoxin A - **Heavy metals**: Lead, arsenic, cadmium, and mercury (for inhalable products) Products failing any test cannot be sold and must be destroyed or remediated according to OLCC protocols. The state maintains a public database of test results, creating transparency around product safety and potency.

Federal Law Conflicts

Despite state legalization, cannabis remains a Schedule I controlled substance under the Controlled Substances Act (21 U.S.C. § 812), creating ongoing legal tensions. Oregon-licensed cannabis businesses cannot access federal banking services, claim ordinary business deductions under Internal Revenue Code Section 280E, or transport products across state lines without violating federal law. The 2018 Farm Bill (Agriculture Improvement Act of 2018, Pub. L. 115-334) legalized hemp containing less than 0.3 percent THC, creating a parallel regulatory track for hemp-derived CBD products that Oregon regulates through the Oregon Department of Agriculture rather than the OLCC. This bifurcated system creates confusion and compliance challenges, particularly around delta-8 THC and other hemp-derived intoxicating cannabinoids.

Market and Business Implications

Oregon's cannabis market dynamics—characterized by oversupply, price compression, and regulatory costs—create challenging conditions for operators while offering lessons for investors and policymakers.

Market Size and Structure

Oregon's legal cannabis market generated approximately $1.2 billion in retail sales during 2025, representing roughly 4 percent annual growth—a significant deceleration from the 20-30 percent annual growth rates observed between 2017 and 2020. The market serves Oregon's 4.2 million residents plus tourists, creating per-capita annual consumption of approximately $285, among the highest rates nationally. The retail sector comprises approximately 1,100 active dispensaries, creating a ratio of roughly one dispensary per 3,800 residents—the highest retail density in the United States. Portland hosts more than 200 dispensaries, while Eugene, Salem, and Bend each have 50-80 locations. This retail saturation intensifies price competition and compresses margins.

Wholesale Price Dynamics

Wholesale cannabis prices in Oregon collapsed between 2016 and 2026, fundamentally altering business economics. Wholesale flower prices averaged approximately: - **2016**: $1,500 per pound - **2018**: $500 per pound - **2020**: $300 per pound - **2022**: $250 per pound - **2025**: $200-$250 per pound for premium indoor, $100-$150 for outdoor These prices fall below production costs for many cultivators, particularly those operating smaller indoor facilities with high electricity and labor costs. Outdoor cultivators with low-cost production capacity remain marginally profitable, but face quality perception challenges and seasonal harvest gluts that further depress prices. Concentrate and extract wholesale prices followed similar trajectories, with distillate prices falling from $15-$20 per gram in 2017 to $3-$5 per gram by 2025. Only premium live resin and solventless concentrates maintain wholesale prices above $10 per gram.

Retail Pricing and Margins

Retail cannabis prices in Oregon rank among the lowest nationally. As of mid-2026, typical retail prices include: - **Flower**: $4-$8 per gram for mid-tier products, $8-$12 for premium indoor - **Pre-rolls**: $3-$5 for single joints, $10-$15 for multi-packs - **Edibles**: $10-$15 for 100mg THC packages - **Concentrates**: $15-$25 per gram for distillate, $30-$50 for live resin Retailers typically operate on 30-40 percent gross margins before the 17 percent state tax and any local taxes, leaving net margins of 10-15 percent for efficiently operated dispensaries. Many retailers operate at break-even or losses, sustained by owner equity or ancillary revenue streams.

Investment Climate

Oregon's compressed margins and regulatory uncertainty create a challenging environment for cannabis investment. Multi-state operators (MSOs) maintain limited presence in Oregon compared to higher-margin markets like Illinois, Massachusetts, or New York. Most Oregon cannabis businesses remain locally owned and operated, often undercapitalized and unable to access institutional investment. The pending merger of cannabis and psilocybin regulatory divisions signals potential regulatory instability that further deters investment. Investors increasingly view Oregon as a mature, low-growth market offering limited return potential compared to emerging adult-use states or medical markets with supply constraints.

Interstate Diversion Concerns

Oregon's oversupply and low prices create economic incentives for interstate diversion. Federal authorities have documented numerous cases of Oregon-grown cannabis trafficked to non-legal states where wholesale prices remain substantially higher. The U.S. Attorney's Office for the District of Oregon prosecuted 15 major diversion cases in 2025, involving more than 10,000 pounds of cannabis and dozens of nominally licensed producers. This diversion undermines Oregon's regulatory credibility and creates federal enforcement risks for compliant operators. The OLCC has enhanced cooperation with federal authorities, sharing licensing and tracking data to identify suspicious activity, but resource constraints limit enforcement effectiveness.

What Experts and Stakeholders Say

Industry representatives, regulators, and policy analysts offer divergent perspectives on Oregon's regulatory challenges and potential solutions. Cannabis industry advocates argue that Oregon's regulatory costs and compliance burdens disproportionately affect small operators while failing to address the fundamental oversupply problem. According to the Oregon Cannabis Association, the state should implement stricter canopy caps, limit new license issuance, and enhance enforcement against unlicensed operators to stabilize the market. The association has called for reducing licensing fees and streamlining compliance requirements to lower operating costs for struggling businesses. Regulatory officials at the OLCC emphasize that the agency operates under statutory constraints and budget limitations that restrict enforcement capacity. According to public statements from OLCC leadership, the commission requires additional funding to hire more compliance investigators, enhance tracking system capabilities, and coordinate with federal authorities on diversion cases. The proposed merger with psilocybin regulation aims to achieve administrative efficiencies without reducing regulatory effectiveness. Public health researchers studying Oregon's cannabis market have documented both positive and negative outcomes. Youth cannabis use rates in Oregon remain statistically unchanged since legalization, according to Oregon Health Authority surveys, suggesting that regulated access has not increased adolescent consumption. However, cannabis-involved traffic fatalities increased approximately 30 percent between 2014 and 2024, though researchers note difficulty isolating cannabis as a causal factor due to polysubstance use and improved detection methods. Local government officials in jurisdictions that banned cannabis businesses express concerns about illegal operators and enforcement challenges. According to statements from county sheriffs in rural Oregon, unlicensed cultivation operations proliferate in areas with cannabis bans, creating environmental damage, water theft, and public safety risks without generating tax revenue for enforcement. Patient advocates defending the medical marijuana program argue that the recreational market's low prices and broad access have undermined the medical program's distinct benefits, including higher possession limits and tax exemptions. Some advocates call for preserving medical program funding and enhancing protections for patient cultivation rights as the programs continue converging.

What's Next: Future Developments and Decision Points

Oregon's cannabis regulatory landscape faces several critical decision points in 2026-2027 that will shape market structure, enforcement capacity, and program sustainability.

Regulatory Merger Implementation

The announced merger of cannabis and psilocybin regulatory divisions will proceed through late 2026 and early 2027, requiring legislative approval during the 2027 session. Key implementation questions include organizational structure, staffing levels, budget allocation, and whether the merged entity remains within the OLCC or transfers to another agency. Industry stakeholders will closely monitor whether the merger achieves promised efficiencies or reduces regulatory capacity.

Federal Rescheduling Impact

The Drug Enforcement Administration's ongoing rulemaking to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act will significantly affect Oregon operators if finalized. Rescheduling would allow cannabis businesses to claim ordinary business deductions under Internal Revenue Code Section 280E, potentially improving profitability by 15-30 percent. However, rescheduling would also subject cannabis to FDA regulation as a drug, creating new compliance requirements and potential conflicts with state regulatory frameworks.

Market Stabilization Measures

The Oregon legislature will likely consider additional market stabilization proposals during the 2027 session, potentially including stricter canopy caps, license limits, or enhanced enforcement funding. Industry groups continue advocating for measures to reduce license numbers and production capacity, though such proposals face opposition from existing licensees and free-market advocates.

Interstate Commerce Prospects

If Congress passes legislation permitting interstate cannabis commerce—such as the proposed STATES Act or similar federalism-based reforms—Oregon's low-cost production capacity could position the state as a major exporter to higher-price markets. However, interstate commerce would also expose Oregon producers to competition from lower-cost outdoor cultivation in California and other states, with uncertain net effects on Oregon's market.

Local Control Evolution

Several Oregon cities and counties will vote on cannabis business bans or approvals in November 2026 elections, potentially expanding or contracting retail access. These local decisions will affect market geography and competitive dynamics, particularly in currently underserved regions.

Further Reading and Primary Sources

• Oregon Liquor and Cannabis Commission official website and administrative rules: https://www.oregon.gov/olcc/cannabis/Pages/default.aspx
• Oregon Revised Statutes Chapter 475C (Cannabinoid Products): https://www.oregonlegislature.gov/bills_laws/ors/ors475C.html
• Oregon Health Authority Medical Marijuana Program: https://www.oregon.gov/oha/PH/DISEASESCONDITIONS/CHRONICDISEASE/MEDICALMARIJUANAPROGRAM/Pages/index.aspx
• Oregon Cannabis Tracking System (CTS/METRC): https://oregon.metrc.com
• Oregon Department of Revenue cannabis tax data and reports: https://www.oregon.gov/dor/programs/gov-research/Pages/research-marijuana.aspx
• Measure 91 full text (2014 ballot initiative): https://ballotpedia.org/Oregon_Marijuana_Legalization,_Measure_91_(2014)
• Oregon Cannabis Association industry advocacy and policy positions: https://www.oregoncannabisassociation.org
• U.S. Attorney's Office for the District of Oregon press releases on cannabis enforcement: https://www.justice.gov/usao-or
• Oregon Health Authority cannabis-related public health data: https://www.oregon.gov/oha/PH/PREVENTIONWELLNESS/MARIJUANA/Pages/index.aspx
• Willamette Week cannabis policy coverage and investigative reporting: https://www.wweek.com